Kevin M. Sun - 05 Mar 2024 Form 4/A Insider Report for DermTech, Inc.

Role: Chief Financial Officer
Signature: /s/ Jason S. Miller, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 05 Mar 2024
Net transactions value: $0
Form type: 4/A
Filing time: 12 Mar 2024, 20:11:15 UTC
Date Of Original Report: 07 Mar 2024
Previous filing: 11 Dec 2023
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DMTK	Common Stock						275,051	05 Mar 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 7, 2024, the reporting person filed a Form 4, which inadvertently omitted from the amounts of securities beneficially owned following the reported transactions in column 5 of such Form 4 the 2,500 shares acquired under the issuer's Employee Stock Purchase Plan on February 29, 2024 (as described in footnote 2 of such Form 4). In fact, as reported in this amendment, following such transactions the reporting person beneficially owned 275,051 shares of common stock of the issuer.

Content

On March 7, 2024, the reporting person filed a Form 4, which inadvertently omitted from the amounts of securities beneficially owned following the reported transactions in column 5 of such Form 4 the 2,500 shares acquired under the issuer's Employee Stock Purchase Plan on February 29, 2024 (as described in footnote 2 of such Form 4). In fact, as reported in this amendment, following such transactions the reporting person beneficially owned 275,051 shares of common stock of the issuer.